Medical Retina

2014 Second Module

3 February – 7 February 2014, Lugano/Switzerland

Scientific coordinators:
Borja Corcóstegui, Bruno Falcomatà

 
MONDAY, 3 FEBRUARY 2014
08:30 Opening remarks  
09:00 Clinical aspects and diagnosis of non-infectious uveitis Phuc LeHoang, France
09:45 Therapeutic management, prognosis, and follow-up of non-infectious uveitis
10:30 COFFEE BREAK
10:45 New therapies for non-infectious uveitis
11:00 Clinical case presentations and discussion of non-infectious uveitis
11:45 Diabetic macular edema surgery: When does it resolve DME, when does it supplement anti-VEGF therapy, when is it ineffective? Anselm Kampik, Germany
12:30 LUNCH
13:30 Diabetic retinopathy-masquerading entities
14:00 New treatments for proliferative diabetic retinopathy
14:30 Complications of the treatments for proliferative diabetic retinopathy
15:00 Central serous chorioretinopathy: Clinical aspects and treatment Alain Gaudric, France
16:00 – 17:00 Central serous chorioretinopathy: Clinical case presentations and discussion
     
TUESDAY, 4 FEBRUARY 2014
08:45 Neovascular AMD: Role of imaging from diagnosis and prognosis to treatment management Paolo Lanzetta, Italy
10:00 COFFEE BREAK
10:15 Intravitreal anti-VEGF treatment for neovascular AMD: a story of choices:
When to start, what type of lesions are we facing, which regimen of treatment should be applied, can we stabilize CNV in the long term without losing vision, when to discontinue treatment
11:30 Clinical importance of the pharmacokinetics of intraocular drugs
(anti-VEGF, steroids, antibiotics)
Carsten Meyer, Switzerland
12:00 Bevacizumab, ranibizumab, aflibercept: which one is more durable?
12:30 LUNCH
13:30 Neovascular maculopathies other than AMD: differential diagnosis and treatment Paolo Lanzetta, Italy
14:30 – 15:30 Dry AMD: staging and role of imaging
     
WEDNESDAY, 5 FEBRUARY 2014
08:45 Diabetic macular edema: Clinical aspects and prognostic factors for visual recovery Giovanni Staurenghi, Italy
09:30 Diabetic macular edema: Medical, laser, intravitreal anti-VEGF, and corticosteroid treatments
10:15 COFFEE BREAK
10:30 Individualized treatments for diabetic macular edema: combining time-sparing, efficacy, and cost-effectiveness
11:15 Non-perfused retinal vein occlusion: laser photocoagulation and new treatments Bora Eldem, Turkey
12:30 LUNCH
13.30 Non-perfused retinal vein occlusion: Clinical case presentations and discussion Bora Eldem, Turkey
14:15 Comparing RVO trials and OCT in venous occlusions
15:15 COFFEE BREAK
15:30 – 16:30 Diabetic macular edema: Clinical cases presentation and discussion Giovanni Staurenghi, Italy
   
THURSDAY, 6 FEBRUARY 2014
09:15 Retinal vein occlusion: Patient management, clinical aspects, prognostic factors, and choice of treatment Gisbert Richard, Germany
10.00 Macular edema in retinal vein occlusion: Treatments, follow-up, and long-term results
10:30 COFFEE BREAK
10:45 – 11:45 Macular edema in retinal vein occlusion: Clinical case presentations and discussion
12:30 LUNCH
13:30 Clinical aspects and diagnosis of infectious uveitis Carlos Pavesio, UK
14:15 Therapeutic management of infectious uveitis
14:45 Follow-up and prognosis of infectious uveitis
15:15 Treatment of uveitis-related cystoid macular edema
16:15 – 17:00 Clinical case presentations and discussion of infectious uveitis
 
FRIDAY, 7 FEBRUARY 2014
  Optical Coherence Tomography (OCT) Course;
Coordinator: Bruno Lumbroso, Italy
 
09:00 OCT technical presentation  
09:30 OCT en face clinical applications Bruno Lumbroso, Italy
09:45 OCT macular microstructure and aspects of macular edema
10:00 OCT and choroid disorders
10:15 COFFEE BREAK  
10:30 OCT in myopic macula Pearse A. Keane, UK
10:45 OCT enface in macular surgery Micol Alkabes, Italy
11:00 Drusen in Age-Related Macular Degeneration: Classification and OCT Findings Pearse A. Keane, UK
11:15 OCT in wet AMD: type, activity and evolution Micol Alkabes, Italy
11:30 OCT in uveitis Luisa Pierro, Italy
11:45 OCT prognostic factors in macular edema
12:00 Modifications of diabetic macular edema
12:15 Mystery OCTs (clinical cases) Micol Alkabes, Italy
12:30 Discussion  
12:45 – 13:15 Certificates and farewell